FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 334:993-994 April 11, 1996 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Strategies to prevent congenital toxoplasmosis remain controversial. In France, all pregnant women who are seronegative for antibodies to Toxoplasma gondii are tested monthly for toxoplasmosis despite the lack of evidence of the cost effectiveness or efficacy of prenatal or postnatal treatment.

Women infected during pregnancy are routinely referred to our center and treated either with sulfadoxine (3 g per day) and pyrimethamine (50 mg per day) for three weeks, alternating with spiramycin (9 million units per day) for three weeks until delivery; or with spiramycin alone (9 million units per day) until delivery. From 1973 through 1990, . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Lefevre-Pettazzoni, M., Bissery, A., Wallon, M., Cozon, G., Peyron, F., Rabilloud, M. (2007). Impact of Spiramycin Treatment and Gestational Age on Maturation of Toxoplasma gondii Immunoglobulin G Avidity in Pregnant Women. CVI 14: 239-243 [Abstract] [Full Text]  
• Stanford, M R, Tan, H K, Gilbert, R E (2006). Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK survey. Br J Ophthalmol 90: 1464-1467 [Abstract] [Full Text]  
• Ferrandiz, J., Mercier, C., Wallon, M., Picot, S., Cesbron-Delauw, M.-F., Peyron, F. (2004). Limited Value of Assays Using Detection of Immunoglobulin G Antibodies to the Two Recombinant Dense Granule Antigens, GRA1 and GRA6 Nt of Toxoplasma gondii, for Distinguishing between Acute and Chronic Infections in Pregnant Women. CVI 11: 1016-1021 [Abstract] [Full Text]  
• Wallon, M., Kodjikian, L., Binquet, C., Garweg, J., Fleury, J., Quantin, C., Peyron, F. (2004). Long-Term Ocular Prognosis in 327 Children With Congenital Toxoplasmosis. Pediatrics 113: 1567-1572 [Abstract] [Full Text]  
• GILBERT, R. E, STANFORD, M. R (2000). Is ocular toxoplasmosis caused by prenatal or postnatal infection?. Br J Ophthalmol 84: 224-226 [Full Text]  
• Wallon, M., Liou, C., Garner, P., Peyron, F. (1999). Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ 318: 1511-1514 [Abstract] [Full Text]